ResearcherMassachusetts Institute of TechnologyNo recent work listed
Laura V. Danai
Matched on ORCID iD 0000-0002-8206-8003; OpenAlex author ID A5030750875; NIH RePORTER profile ID 11152809. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 1
- Labs led
- 0
- Collaborators
- 27
2017: 1 grant · 2018: 2 papers · 2019: 1 paper · 2020: 1 paper
Papers 4
- Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma. Co-author DOI 10.7554/elife.56782↗
- Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer. Co-author DOI 10.1158/1055-9965.epi-19-0370↗
- Altered exocrine function can drive adipose wasting in early pancreatic cancer. Co-author DOI 10.1038/s41586-018-0235-7↗
- PKM2 is not required for pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s40170-018-0188-1↗
Grants 1
Closest collaborators
The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Matthew G. Vander Heiden · 4 shared papers, 2018–2020 · strength 0.30
- Paper PKM2 is not required for pancreatic ductal adenocarcinoma. DOI 10.1186/s40170-018-0188-1↗
- Paper Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma. DOI 10.7554/elife.56782↗
- Paper Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Adv… DOI 10.1158/1055-9965.epi-19-0370↗
- Allison N. Lau · 3 shared papers, 2018–2020 · strength 0.23
- Paper PKM2 is not required for pancreatic ductal adenocarcinoma. DOI 10.1186/s40170-018-0188-1↗
- Paper Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma. DOI 10.7554/elife.56782↗
- Paper Altered exocrine function can drive adipose wasting in early pancreatic cancer. DOI 10.1038/s41586-018-0235-7↗
- Evan Chen Lien · 2 shared papers, 2018–2020 · strength 0.14
- Jared R. Mayers · 2 shared papers, 2018–2020 · strength 0.14
- Ana Babić · 2 shared papers, 2018–2019 · strength 0.12
- Michael Hayden Rosenthal · 2 shared papers, 2018–2019 · strength 0.12
- Motokazu Sugimoto · 2 shared papers, 2018–2019 · strength 0.12
- Naoki Takahashi · 2 shared papers, 2018–2019 · strength 0.12
- Brian Matthew Wolpin · 2 shared papers, 2018–2019 · strength 0.12
- Gloria M. Petersen · 2 shared papers, 2018–2019 · strength 0.12
- Matthew H. Kulke · 2 shared papers, 2018–2019 · strength 0.12
- Alissandra L. Hillis · 1 shared paper, 2018 · strength 0.09
- David Arthur Tuveson · 1 shared paper, 2020 · strength 0.09
- Giulia Biffi · 1 shared paper, 2020 · strength 0.09
- Tyler Jacks · 1 shared paper, 2020 · strength 0.09
- Richard Francis Dunne · 1 shared paper, 2019 · strength 0.07
- Vicente Morales‐Oyarvide · 1 shared paper, 2019 · strength 0.07
- Kimmie Ng · 1 shared paper, 2019 · strength 0.07
- Natalia I. Khalaf · 1 shared paper, 2019 · strength 0.07
- Albert C. Koong · 1 shared paper, 2018 · strength 0.06
- Chen Yuan · 1 shared paper, 2018 · strength 0.06
- Alexander Muir · 1 shared paper, 2018 · strength 0.06
- Carlos F. Fernandez-del Castillo · 1 shared paper, 2018 · strength 0.06
- Nicole Lopez · 1 shared paper, 2018 · strength 0.06
- Jen Jen Yeh · 1 shared paper, 2018 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.